BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 19051296)

  • 61. Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis.
    Hosoya K; Yamashita S; Ando T; Nakajima T; Itoh F; Ushijima T
    Cancer Lett; 2009 Nov; 285(2):182-9. PubMed ID: 19527921
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Wnt signaling inhibits cementoblast differentiation and promotes proliferation.
    Nemoto E; Koshikawa Y; Kanaya S; Tsuchiya M; Tamura M; Somerman MJ; Shimauchi H
    Bone; 2009 May; 44(5):805-12. PubMed ID: 19442631
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.
    Suzuki H; Watkins DN; Jair KW; Schuebel KE; Markowitz SD; Chen WD; Pretlow TP; Yang B; Akiyama Y; Van Engeland M; Toyota M; Tokino T; Hinoda Y; Imai K; Herman JG; Baylin SB
    Nat Genet; 2004 Apr; 36(4):417-22. PubMed ID: 15034581
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
    Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
    Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
    Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
    [TBL] [Abstract][Full Text] [Related]  

  • 66. RASSF10 is epigenetically silenced and functions as a tumor suppressor in gastric cancer.
    Wei Z; Chen X; Chen J; Wang W; Xu X; Cai Q
    Biochem Biophys Res Commun; 2013 Mar; 432(4):632-7. PubMed ID: 23428420
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination.
    Cheng XX; Wang ZC; Chen XY; Sun Y; Kong QY; Liu J; Li H
    Cancer Lett; 2005 Jun; 223(2):339-47. PubMed ID: 15896469
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis.
    Veeck J; Geisler C; Noetzel E; Alkaya S; Hartmann A; Knüchel R; Dahl E
    Carcinogenesis; 2008 May; 29(5):991-8. PubMed ID: 18356147
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
    Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer.
    Gopal G; Raja UM; Shirley S; Rajalekshmi KR; Rajkumar T
    Cancer Genet; 2013 May; 206(5):174-82. PubMed ID: 23830730
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer.
    Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
    Anticancer Res; 2006; 26(6B):4267-70. PubMed ID: 17201143
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Beta-catenin expression in relation to genetic instability and prognosis in colorectal cancer.
    Mårtensson A; Oberg A; Jung A; Cederquist K; Stenling R; Palmqvist R
    Oncol Rep; 2007 Feb; 17(2):447-52. PubMed ID: 17203186
    [TBL] [Abstract][Full Text] [Related]  

  • 73. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
    Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
    Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
    Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
    [TBL] [Abstract][Full Text] [Related]  

  • 76. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
    Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
    Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
    Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.
    Horst D; Reu S; Kriegl L; Engel J; Kirchner T; Jung A
    Cancer; 2009 May; 115(10):2063-70. PubMed ID: 19298008
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival.
    Xu L; Li X; Chu ES; Zhao G; Go MY; Tao Q; Jin H; Zeng Z; Sung JJ; Yu J
    Gut; 2012 Jul; 61(7):977-85. PubMed ID: 21917650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.